Review



cd45ro antibody  (NSJ Bioreagents)


Bioz Verified Symbol NSJ Bioreagents is a verified supplier
Bioz Manufacturer Symbol NSJ Bioreagents manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    NSJ Bioreagents cd45ro antibody
    Cd45ro Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 634 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ro antibody/product/NSJ Bioreagents
    Average 99 stars, based on 634 article reviews
    cd45ro antibody - by Bioz Stars, 2026-06
    99/100 stars

    Images



    Similar Products

    99
    NSJ Bioreagents cd45ro antibody
    Cd45ro Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ro antibody/product/NSJ Bioreagents
    Average 99 stars, based on 1 article reviews
    cd45ro antibody - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec 651 cd45ro viogreen
    651 Cd45ro Viogreen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/651 cd45ro viogreen/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    651 cd45ro viogreen - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec cd45ro viogreen
    Cd45ro Viogreen, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ro viogreen/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    cd45ro viogreen - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    86
    Celgene anti cd45ro antibodies
    Flow cytometric evaluation of T-cell subpopulation dynamics in ADHD and HC groups. (A) Gating protocol for T-cell subset analysis. (B-I) Comparative analysis of T-cell subset distributions. ROC curves for (J) CD4 + <t>CD45RO</t> + T cells, (K) CD4 + CD45RO − T cells, (L) CD8 + CD28 − T cells, (M) CD8 + CD45RO + T cells, and (N) CD8 + CD45RO − T cells. (O) ROC analysis and (P) parameter covariance plots for logistic regression modeling. Data are displayed as mean ± standard deviation, with individual participants represented by data points (technical duplicates averaged). Statistical comparisons utilized one-way analysis of variance with Tukey’s post-hoc tests **, P<0.01; ***, P<0.001; ns, non-significant. ADHD, attention-deficit/hyperactivity disorder; AUC, area under the curve; HC, healthy control; ROC, receiver operating characteristic.
    Anti Cd45ro Antibodies, supplied by Celgene, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd45ro antibodies/product/Celgene
    Average 86 stars, based on 1 article reviews
    anti cd45ro antibodies - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd45ra cd45ro cxcr5 nt reg
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Cd45ra Cd45ro Cxcr5 Nt Reg, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ra cd45ro cxcr5 nt reg/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    cd45ra cd45ro cxcr5 nt reg - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd45ra cd45ro cxcr5 pretfr cells
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Cd45ra Cd45ro Cxcr5 Pretfr Cells, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45ra cd45ro cxcr5 pretfr cells/product/Miltenyi Biotec
    Average 96 stars, based on 1 article reviews
    cd45ra cd45ro cxcr5 pretfr cells - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec anti cd45ro apc
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Anti Cd45ro Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd45ro apc/product/Miltenyi Biotec
    Average 93 stars, based on 1 article reviews
    anti cd45ro apc - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    95
    Miltenyi Biotec anti human cd45ro
    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and <t>CXCR5</t> expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.
    Anti Human Cd45ro, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti human cd45ro/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti human cd45ro - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    Image Search Results


    Flow cytometric evaluation of T-cell subpopulation dynamics in ADHD and HC groups. (A) Gating protocol for T-cell subset analysis. (B-I) Comparative analysis of T-cell subset distributions. ROC curves for (J) CD4 + CD45RO + T cells, (K) CD4 + CD45RO − T cells, (L) CD8 + CD28 − T cells, (M) CD8 + CD45RO + T cells, and (N) CD8 + CD45RO − T cells. (O) ROC analysis and (P) parameter covariance plots for logistic regression modeling. Data are displayed as mean ± standard deviation, with individual participants represented by data points (technical duplicates averaged). Statistical comparisons utilized one-way analysis of variance with Tukey’s post-hoc tests **, P<0.01; ***, P<0.001; ns, non-significant. ADHD, attention-deficit/hyperactivity disorder; AUC, area under the curve; HC, healthy control; ROC, receiver operating characteristic.

    Journal: Translational Pediatrics

    Article Title: Evaluation of circulating lymphocyte subsets in children with attention-deficit hyperactivity disorder

    doi: 10.21037/tp-2025-362

    Figure Lengend Snippet: Flow cytometric evaluation of T-cell subpopulation dynamics in ADHD and HC groups. (A) Gating protocol for T-cell subset analysis. (B-I) Comparative analysis of T-cell subset distributions. ROC curves for (J) CD4 + CD45RO + T cells, (K) CD4 + CD45RO − T cells, (L) CD8 + CD28 − T cells, (M) CD8 + CD45RO + T cells, and (N) CD8 + CD45RO − T cells. (O) ROC analysis and (P) parameter covariance plots for logistic regression modeling. Data are displayed as mean ± standard deviation, with individual participants represented by data points (technical duplicates averaged). Statistical comparisons utilized one-way analysis of variance with Tukey’s post-hoc tests **, P<0.01; ***, P<0.001; ns, non-significant. ADHD, attention-deficit/hyperactivity disorder; AUC, area under the curve; HC, healthy control; ROC, receiver operating characteristic.

    Article Snippet: PE-conjugated anti-CD127 and APC-conjugated anti-CD45RO antibodies were purchased from Jiangxi Celgene Biotechnology (China) for identifying regulatory and memory T-cell subsets.

    Techniques: Standard Deviation, Control

    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Journal: Science Advances

    Article Title: Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections

    doi: 10.1126/sciadv.adv6939

    Figure Lengend Snippet: ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Article Snippet: For in vitro cell expansion, 4 × 10 3 CD45RA + CD45RO − CXCR5 − nT reg or 3 × 10 3 CD45RA + CD45RO − CXCR5 + preTfr cells were activated by human T reg expander beads (Miltenyi Biotec) and cytokine cocktails of IL-2 (500 IU/ml; Shionogi), activin A (100 ng/ml; PeproTech), and IL-12 (1 ng/ml; PeproTech).

    Techniques: Flow Cytometry, Expressing, Gene Expression, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Suppression Assay, Comparison

    ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Journal: Science Advances

    Article Title: Human precursor T follicular regulatory cells are primed for differentiation into mature Tfr and disrupted during severe infections

    doi: 10.1126/sciadv.adv6939

    Figure Lengend Snippet: ( A ) Schematic diagram outlining the study design for TPC. Created in BioRender. Wing, J. (2025) https://BioRender.com/qx390a1 . TGF-β, transforming growth factor–β. ( B ) Flow cytometry analysis showing the levels of BCL6 and CXCR5 expression in T regs from different groups. Statistics: Repeated measures one-way ANOVA with a Holm-Sidak posttest, n = 6 (FMO only, n = 3). ( C ) PCA plot visualizing the gene expression profiles of TPC- and IL-2–treated T regs and Tfr cells. ( D ) Volcano plot depicting DEGs between nT reg -TPC (blue) and preTfr-TPC (red) populations. Statistics: edgeR corrected for donor differences, n = 3 per condition. ( E ) mRNA expression level of selected genes. Statistical significance (adjusted P values from edgeR) is indicated with * P < 0.05, ** P < 0.01, and *** P < 0.001. ( F ) Boxplot showing protein expression level of ILRA determined by ELISA of T reg subset SNs. Statistics: Two-tailed paired t test, n = 6. ( G ) Boxplots of plasmablast suppression assay in total PBMCs treated with TPC culture SNs. Statistics: edgeR corrected for donor differences, n = 3 to 4 per condition (unstim, n = 2 but not used for statistical comparison). Hinges correspond to the first and third quartiles, center line is median, and whiskers correspond to the 1.5 times interquartile range. FMO, flourescence minus one; unstim, unstimulated.

    Article Snippet: For in vitro cell expansion, 4 × 10 3 CD45RA + CD45RO − CXCR5 − nT reg or 3 × 10 3 CD45RA + CD45RO − CXCR5 + preTfr cells were activated by human T reg expander beads (Miltenyi Biotec) and cytokine cocktails of IL-2 (500 IU/ml; Shionogi), activin A (100 ng/ml; PeproTech), and IL-12 (1 ng/ml; PeproTech).

    Techniques: Flow Cytometry, Expressing, Gene Expression, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Suppression Assay, Comparison